Combined Triple Procedure in Retinal Vein Occlusion (RVO)

• Status: Completed
• Trial end date: 2008-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this pilot study was to investigate the effects of an intravitreal combination therapy using triamcinolone and bevacizumab in patients with retinal vein occlusion (RVO).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Johann Wolfgang Goethe University Hospital
• Treatments: Bevacizumab; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Ischemic central RVO (CRVO)

• Non-ischemic CRVO

• Branch RVO (BRVO)

Exclusion Criteria:

• Visual deterioration due to acute or chronic inflammation

• Post trauma

• Macular edema of other origin

• Intravitreal drug treatment within last 4 months